Key Takeaways GLP-1 drugs offer potentially extensive benefits to people with psoriasisPsoriasis patients had a 78% lower ...

It’s a trending topic: weight loss medication. But which one might be right for you? 7 News sat down with doctors from Bon ...

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

Compared with usual care, GLP-1 receptor agonists tirzepatide and semaglutide may be cost-effective options for patients with ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

The weight-loss drug boom has, in many ways, turned into a generational market story. For perspective, the U.S. obesity ...

The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

Serena Williams has shared a cryptic post on social media about going through some challenging times just a few weeks after ...

Weight-loss drugs such as Wegovy, Zepbound, and other GLP-1 medications are no longer covered for TRICARE For Life (TFL) ...

Elevance Health Inc. was hit with a proposed class action by a woman who says the insurer wrongly refuses to cover the weight-loss drug Zepbound for patients who need it to treat obstructive sleep ...